Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19

Clinical trial NCT04306393 · COMPLETED

Trial details

NCT number: NCT04306393
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

SARS (Severe Acute Respiratory Syndrome)Coronavirus

Start date: 2020-03-21
Primary completion: 2021-12-21
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.